The approach only works for a specific genetic subtype of bowel cancer, and the researchers now say they can predict who it ...

For the hundreds of thousands of people who undergo sphincter-preserving surgery for rectal cancer each year, saving the ...

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific ...

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...

When someone is diagnosed with colorectal cancer—which includes both colon and rectal cancers—many people immediately think "surgery." And it's true that surgery plays a central role in treatment for ...

Add Yahoo as a preferred source to see more of our stories on Google. Zoe Gardner-Lawson, pictured before and after bowel cancer surgery. (SWNS) Zoe Gardner-Lawson, 36, an HR manager and mum-of-three ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...

I was hospitalized for the first time in my life for colon cancer surgery—it was okay to say, 'I'm scared'In my previous ...

Tecentriq is now the first immunotherapy indicated for dMMR colon cancer treatment specifically, which is often linked to a higher risk of progression after surgery.

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...